🇨🇿 Dr. Sarah Mitchell

Photo by Jonathan Borba / Pexels · illustrative, not a photo of the physician

About Dr. Sarah Mitchell

Dr. Sarah Mitchell is a British consultant reproductive medicine specialist who relocated to Brno, Czech Republic in 2012, drawn by Reprofit International’s world-class IVF laboratory and the opportunity to work with an internationally diverse patient population. With over 2,100 IVF cycles to her name, Dr. Mitchell has developed particular expertise in complex cases: recurrent implantation failure, immunological infertility, and patients who have had multiple failed cycles at other clinics.

Dr. Mitchell completed her specialist training at Hammersmith Hospital, London — one of the UK’s leading reproductive medicine centers — and subsequently undertook a fellowship at Reproductive Biology Associates (RBA) in Atlanta, one of the USA’s most research-active IVF centers. Her PhD research, completed at Masaryk University, focused on endometrial receptivity and implantation failure — directly informing her clinical approach to difficult IVF cases.

Dr. Mitchell has a particular reputation for honest, compassionate communication with patients — she presents outcome data transparently and supports patients through unsuccessful cycles with the same attentiveness as successful ones.

Education & Training

• MBBCh — University of Cape Town, South Africa, 2001
• MRCOG (Member of the Royal College of Obstetricians & Gynaecologists) — London, 2006
• Subspecialty Training in Reproductive Medicine — Hammersmith Hospital, London, 2008–2010
• Fellowship in Advanced IVF — Reproductive Biology Associates, Atlanta, USA, 2010–2011
• PhD in Reproductive Immunology — Masaryk University, Brno, 2016

Clinical Philosophy

Dr. Mitchell's clinical practice is built around what she describes as "honest statistics" — presenting patients with live birth rates per embryo transfer for their specific age band and diagnosis, rather than the more favourable per-cycle-started or per-retrieval figures that inflate apparent success rates. She has been vocal in professional forums about the fertility industry's tendency toward selective statistical presentation, describing it as "the single most consequential dishonesty in reproductive medicine marketing."

Her approach to embryo transfer numbers is similarly evidence-driven: she recommends single embryo transfer for good-prognosis patients even though double transfers produce higher headline pregnancy rates, because the multiple-pregnancy complications that follow — premature birth chief among them — represent a worse outcome for both mother and babies despite the more impressive statistic. "A twin pregnancy is not a bonus outcome," she has stated. "It is a complication we should actively work to avoid in patients where a healthy singleton pregnancy is achievable."

What Patients Should Know Before Consulting Dr. Sarah Mitchell

International patients seeking reproductive medicine and IVF treatment should approach any initial consultation prepared with complete medical records, realistic expectations about timelines, and specific questions about individual case volume and complication rates rather than general institutional statistics. A thorough consultation should never feel rushed toward a booking decision — reputable specialists in this field build in time for questions and, where appropriate, will explicitly discuss cases where the requested treatment is not the right option.

Representative Case Types

Dr. Mitchell's international IVF practice at Reprofit International spans the full range of fertility treatment complexity, with particular expertise in cases other clinics have found difficult.

Standard own-egg IVF: For patients under 38 with no major complicating factors, typically achieving live birth rates in line with the clinic's published averages for the age band. Dr. Mitchell is a strong advocate of single embryo transfer for this group despite the marginally lower per-cycle statistic compared to double transfer.

Donor egg programmes: A significant share of her international practice, particularly for patients over 40 or with diminished ovarian reserve. She personally reviews donor matching criteria with each patient, explaining exactly what phenotypic and screening information will and will not be available given the Czech Republic's anonymous donation framework.

Recurrent implantation failure: Patients who have had multiple unsuccessful cycles elsewhere represent some of her most complex cases, often requiring additional investigation (immunological panels, endometrial receptivity testing) before a revised protocol is recommended — investigation she is notably selective about, offering only tests with meaningful evidence behind them for the specific presentation.

Professional Recognition

Dr. Mitchell has overseen more than 2,100 IVF cycles across her career and maintains active fellowship status with the Royal College of Obstetricians and Gynaecologists (MRCOG). She has spoken at European fertility conferences on transparent statistical reporting in IVF marketing, an area where she has been an outspoken advocate for higher industry standards.

Patients beginning an IVF journey with Dr. Mitchell can expect an unusually candid first consultation — she is known for discussing statistical realities plainly, including scenarios where a patient's age or diagnosis suggests donor eggs may offer meaningfully better odds than continuing with own-egg cycles, even when that is not what the patient hoped to hear.

Beyond individual patient care, Dr. Mitchell has contributed to professional discussions on standardising IVF success rate reporting across European fertility clinics, arguing that inconsistent statistical presentation between clinics makes genuine cross-clinic comparison needlessly difficult for patients making one of the most significant decisions of their lives.

She maintains that the emotional dimension of fertility treatment deserves equal weight to the clinical dimension: "A patient who understands their real odds and chooses to proceed anyway is making an informed decision. A patient who proceeds based on an inflated statistic is not."

For patients beginning fertility treatment abroad, this distinction between informed and merely hopeful decision-making is, in Dr. Mitchell's clinical experience, the single factor most associated with how patients process both successful and unsuccessful cycles emotionally over time.

It is, in her assessment, the single most important service a fertility specialist provides beyond clinical skill itself — the honest framing that allows patients to make peace with whatever outcome follows.

Patient FAQ